GEn1E Lifesciences is a Clinical-stage, multi-target company with a unique AI platform. They develop novel, next-generation, immunomodulatory therapies for rare & inflammatory diseases with no effective treatments. GEn1E is supercharging the drug development cycle by applying AI to multiple-mechanism-of-action protein targets and their natural platform capabilities—creating novel therapeutics at an unprecedented pace. Their AI platform has enabled them to develop a purpose-built therapy for ARDS to reduce its $20 billion cost on society (just in the USA). GEn1E has built a rich pipeline of 21+ novel and selective immunomodulators and has plans to accelerate 2 additional devastating diseases (beyond their lead indication) to IND in the next 12 months. Their AI platform enables tremendous pace and capital efficiency as demonstrated by their progress in ~2 years with seed capital—a stark contrast to the typical spend of $100M+ and 7+ years exhibited in the pharmaceuticals / biotech industry. With ~90% of rare diseases having no therapeutic treatment at all, GEn1E is taking a giant swing that will hopefully bring life-saving therapies to the lives of patients in need. GEn1E’s team has decades of experience in drug development and machine learning, and they graduated from YCombinator and Stanford-StartX in late 2019. GEn1E is based in Palo Alto, CA.
View Top Employees from GEn1E Lifesciences Inc.Website | https://www.gen1e.com |
Revenue | $13.8 million |
Employees | 16 (10 on RocketReach) |
Founded | 2018 |
Address | 1123 Stanford Ave, Palo Alto, California 94306, US |
Technologies |
JavaScript,
HTML,
Twitter
+9 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Drug Discovery, Healthcare, Science and Engineering, Drug Manufacturing & Research, Life Science |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular GEn1E Lifesciences Inc. employee's phone or email?
The GEn1E Lifesciences Inc. annual revenue was $13.8 million in 2024.
Ritu Lal is the Chief Executive Officer and Co-Founder of GEn1E Lifesciences Inc..
10 people are employed at GEn1E Lifesciences Inc..
GEn1E Lifesciences Inc. is based in Palo Alto, California.
The NAICS codes for GEn1E Lifesciences Inc. are [32, 3254, 32541, 325].
The SIC codes for GEn1E Lifesciences Inc. are [28, 283].